- Release Date: 09/05/22 09:14
- Summary: FDA IND Approval for Phase 3 Study of DMX-200 in FSGS
- Price Sensitive: Yes
- Download Document 305.47KB
Ann: FDA IND Approval for Phase 3 Study of DMX-200 in FSGS
-
- There are more pages in this discussion • 49 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
41.3¢ |
Change
-0.003(0.60%) |
Mkt cap ! $223.0M | |||
| Open | High | Low | Value | Volume |
| 40.5¢ | 41.3¢ | 39.5¢ | $210.2K | 517.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 32518 | 41.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 41.5¢ | 106793 | 5 |
View Market Depth
| Last trade - 12.17pm 08/08/2024 (20 minute delay) ? |
| DXB (ASX) Chart |